Fresolimumab and Radiotherapy in Metastatic Breast Cancer
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test safety of combining fresolimumab and local radiotherapy
and to see if the combination can achieve tumor regression.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine Weill Medical College of Cornell University